| SOX2 in development and cancer biology D Novak, L Hüser, JJ Elton, V Umansky, P Altevogt, J Utikal Seminars in cancer biology 67, 74-82, 2020 | 339 | 2020 |
| Novel insights into the function of CD24: A driving force in cancer P Altevogt, M Sammar, L Hüser, G Kristiansen International Journal of Cancer 148 (3), 546-559, 2021 | 187 | 2021 |
| Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signaling V Fleming, X Hu, C Weller, R Weber, C Groth, Z Riester, L Hüser, Q Sun, ... Cancer Research 79 (18), 4715-4728, 2019 | 131 | 2019 |
| Stromal changes in the aged lung induce an emergence from melanoma dormancy ME Fane, Y Chhabra, GM Alicea, DA Maranto, SM Douglass, MR Webster, ... Nature 606 (7913), 396-405, 2022 | 122 | 2022 |
| IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma R Weber, Z Riester, L Hüser, C Sticht, A Siebenmorgen, C Groth, X Hu, ... Journal for immunotherapy of cancer 8 (2), e000949, 2020 | 97 | 2020 |
| Targeting SOX2 in anticancer therapy L Hüser, D Novak, V Umansky, P Altevogt, J Utikal Expert opinion on therapeutic targets 22 (12), 983-991, 2018 | 83 | 2018 |
| SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma L Hüser, S Sachindra, K Granados, A Federico, L Larribère, D Novak, ... International journal of cancer 143 (12), 3131-3142, 2018 | 71 | 2018 |
| Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target E Orouji, A Federico, L Larribère, D Novak, DB Lipka, Y Assenov, ... International journal of cancer 145 (12), 3462-3477, 2019 | 56 | 2019 |
| TGF‐β induces SOX2 expression in a time‐dependent manner in human melanoma cells K Weina, H Wu, N Knappe, E Orouji, D Novak, M Bernhardt, L Hüser, ... Pigment Cell & Melanoma Research 29 (4), 453-458, 2016 | 44 | 2016 |
| Morphology and connectivity of the small bistratified A8 amacrine cell in the mouse retina SCS Lee, A Meyer, T Schubert, L Hüser, K Dedek, S Haverkamp Journal of Comparative Neurology 523 (10), 1529-1547, 2015 | 42 | 2015 |
| T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells K Granados, L Hüser, A Federico, S Sachindra, G Wolff, T Hielscher, ... British journal of cancer 122 (7), 1023-1036, 2020 | 28 | 2020 |
| New role of ID3 in melanoma adaptive drug-resistance L Larribère, D Novak, H Wu, L Hüser, K Granados, E Orouji, J Utikal Oncotarget 8 (66), 110166, 2017 | 24 | 2017 |
| FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor Q Sun, D Novak, L Hüser, J Poelchen, H Wu, K Granados, A Federico, ... International journal of cancer 149 (3), 657-674, 2021 | 20 | 2021 |
| Cell type-specific bipolar cell input to ganglion cells in the mouse retina S Neumann, L Hüser, K Ondreka, N Auler, S Haverkamp Neuroscience 316, 420-432, 2016 | 16 | 2016 |
| NTPDase2 and the P2Y1 receptor are not required for mammalian eye formation K Gampe, S Haverkamp, SC Robson, C Gachet, L Hüser, A Acker-Palmer, ... Purinergic signalling 11, 155-160, 2015 | 13 | 2015 |
| DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer Y Tolkach, R Zarbl, S Bauer, M Ritter, J Ellinger, S Hauser, L Hüser, ... The American journal of pathology 191 (4), 618-630, 2021 | 12 | 2021 |
| HER3-receptor-mediated STAT3 activation plays a central role in adaptive resistance toward vemurafenib in melanoma L Hüser, MM Kokkaleniou, K Granados, J Dworacek, A Federico, ... Cancers 12 (12), 3761, 2020 | 12 | 2020 |
| Targeted therapy-resistant melanoma cells acquire transcriptomic similarities with human melanoblasts L Larribère, S Kuphal, C Sachpekidis, Sachindra, L Hüser, A Bosserhoff, ... Cancers 10 (11), 451, 2018 | 12 | 2018 |
| Secretogranin II influences the assembly and function of MHC class I in melanoma T Steinfass, J Poelchen, Q Sun, G Mastrogiulio, D Novak, M Vierthaler, ... Experimental Hematology & Oncology 12 (1), 29, 2023 | 9 | 2023 |
| Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies L Hüser, P Altevogt, J Utikal Oncotarget 10 (18), 1662, 2019 | 9 | 2019 |
